Saudi PhD Scholar In US Advances Microbiology And Infectious Diseases Research

Saudi Arabia's young scholars are making their mark globally, with many achieving significant milestones in their respective fields of study. Among these bright minds is Dr. Sarah Alobaid, a name that has become synonymous with innovation and dedication in the realm of microbiology and infectious diseases. As a PhD student in the United States, Dr. Alobaid has been actively contributing to the scientific community while working across three different sectors and holding membership in the American Society for Microbiology (ASM).

Dr. Alobaid's academic journey commenced with her pursuit of a master's degree in molecular and cellular biology at the University of New Haven. Her research there was groundbreaking, focusing on the utilization of magnetic nanoparticles (MNPs- Fe3O4) combined with doxorubicin and electromagnetic radiation to enhance breast cancer treatment in T47D cells. The aim was to develop a targeted drug delivery system that could directly attack cancer cells, potentially improving treatment outcomes and reducing the adverse side effects commonly associated with conventional tumor therapies.

Following her master's degree, Dr. Alobaid embarked on her PhD at George Mason University, specializing in microbiology and infectious diseases. Her dissertation explores the "Role of poly‐gamma-glutamic acid synthesis locus (pgsBCW /capBCA) in Francisella microbial physiology". This research delves into how the "pgsBCW" gene enables Francisella bacteria to survive under extreme conditions and evade the human immune system. Identifying these genes and understanding PGA production in Francisella could pave the way for new therapeutic strategies against these formidable pathogens.

In 2020, Dr. Alobaid's work was recognized as one of the best research projects at George Mason University. She employs sophisticated techniques such as Polymerase Chain Reaction (PCR) and Quantitative Reverse Transcriptase PCR (qRT-PCR) in collaboration with her team to pinpoint key genes responsible for bacterial resilience.

Expressing gratitude towards the leadership of Saudi Arabia, Dr. Alobaid thanked Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al-Saud and His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al-Saud, Crown Prince and Prime Minister, for their unwavering support towards the empowerment and academic excellence of Saudi youth abroad. Their commitment to providing scholarships for Saudi students to attend top universities worldwide is instrumental in nurturing a generation capable of contributing significantly to various scientific fields.

Dr. Sarah Alobaid's achievements not only highlight her personal dedication and skill but also reflect the broader success of Saudi Arabia's educational initiatives on an international stage. Through her work, she aims to introduce safer and more effective cancer treatments, demonstrating the potential impact of Saudi scholars on global health challenges.

With inputs from SPA